Back to the main directory
Press Release
- EQS-News: FORTEC Elektronik AG bestätigt die vorläufigen Zahlen nach 9 Monaten by EQS Group AG
- Net Asset Value(s) by GlobeNewsWire
- EQS-News: FCR Immobilien AG mit guten Geschäftszahlen für das 1. Quartal 2024 by EQS Group AG
- EQS-News: Upheaval at Deutsche Lichtmiete: The controversial successor company Novalumen GmbH is being liquidated. Investor representatives welcome the end of a 'self-enrichment scheme' by EQS Group AG
- Columbus McKinnon Reports Record Net Sales, Gross Margin and Operating Income in Fiscal 2024 by BusinessWire
- Radisson étend son programme de forage à 35 000 m au projet O’Brien by GlobeNewsWire
- Global 50 Manufacturing Giant Trusts eGain for Knowledge-Powered Customer Service by GlobeNewsWire
- Audit Committee Chair Confirmation by GlobeNewsWire
- Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides by GlobeNewsWire
- Castellum, Inc. Announces Leadership Changes by GlobeNewsWire
- Advance Auto Parts Announces Merchandising Leadership Changes; Names Bruce Starnes Executive Vice President, Chief Merchant by BusinessWire
- Kymera Therapeutics to Participate in Upcoming June Investor Conferences by GlobeNewsWire
- IGM Biosciences to Present at the Jefferies Healthcare Conference by GlobeNewsWire
- MediWound Reports First Quarter 2024 Financial Results and Provides Company Update by GlobeNewsWire
- Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024 by GlobeNewsWire
- OTC Markets Group Welcomes Marpai, Inc. to OTCQX by GlobeNewsWire
- Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer by GlobeNewsWire
- Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference by GlobeNewsWire
- ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024 by GlobeNewsWire
- TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies by GlobeNewsWire
- Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024 by GlobeNewsWire
- Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference by GlobeNewsWire
- Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors by GlobeNewsWire
- Athira Pharma to Participate in Upcoming June Conferences by GlobeNewsWire
- Lotus Technology Reports Unaudited First Quarter 2024 Financial Results by GlobeNewsWire